Indofarma Tbk PT. Stock Analysis INAF.JK

PT Indofarma Tbk engages in the provision of pharmaceutical and healthcare businesses. The company is headquartered in Bekasi, Jawa Barat and currently employs 21 full-time employees. The company went IPO on 2001-04-17. The company is primarily engaged in the manufacturing and distribution of pharmaceutical products, traditional medicines, medical devices, health supplements, toll manufacturing, and laboratory testing services. The Company’s segments include Medicine, Medical devices and others, and Engineering pharmaceutical. Its products and services include generic drugs, over-the-counter and food, medical devices, non-medical devices, and household health products. The company carries out business activities to produce, either alone or under cooperation, for finished drug products, such as essential medicines, generic medicines with logos, generic medicines with trade names, traditional medicines, medical equipment, diagnostics, as well as food products, both related to health maintenance and improvement as well as health restoration.